{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:05:42Z","timestamp":1790687142423,"version":"4.1.0"},"reference-count":107,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T00:00:00Z","timestamp":1684540800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cell Biology"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.ejcb.2023.151326","type":"journal-article","created":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T02:13:17Z","timestamp":1685671997000},"page":"151326","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Challenges and future perspective of antisense therapy for spinal muscular atrophy: A review"],"prefix":"10.1016","volume":"102","author":[{"given":"Zorica","family":"Nakevska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshifumi","family":"Yokota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejcb.2023.151326_bib1","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1089\/oli.2009.0211","article-title":"The biological effect of an antisense oligonucleotide depends on its route of endocytosis and trafficking","volume":"20","author":"Alam","year":"2010","journal-title":"Oligonucleotides"},{"key":"10.1016\/j.ejcb.2023.151326_bib2","doi-asserted-by":"crossref","first-page":"e1312","DOI":"10.1212\/WNL.0000000000006281","article-title":"Nusinersen in patients older than 7 months with spinal muscular atrophy type 1","volume":"91","author":"Aragon-Gawinska","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.ejcb.2023.151326_bib3","first-page":"11","article-title":"Restoring SMN expression: an overview of the therapeutic developments for the treatment of spinal muscular atrophy","author":"Aslesh","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.ejcb.2023.151326_bib4","first-page":"8","article-title":"DG9-conjugated morpholino rescues phenotype in SMA mice by reaching the CNS via a subcutaneous administration","author":"Aslesh","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.ejcb.2023.151326_bib5","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1007\/s13311-014-0293-y","article-title":"Spinal muscular atrophy: journeying from bench to bedside","volume":"11","author":"Awano","year":"2014","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.ejcb.2023.151326_bib6","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.molcel.2006.05.036","article-title":"The gemin5 protein of the SMN complex identifies snRNAs","volume":"23","author":"Battle","year":"2006","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ejcb.2023.151326_bib7","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1146\/annurev-pharmtox-010716-104846","article-title":"Pharmacology of antisense drugs","volume":"57","author":"Bennett","year":"2017","journal-title":"Annu Rev. Pharm. Toxicol."},{"key":"10.1016\/j.ejcb.2023.151326_bib8","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.celrep.2017.10.010","article-title":"In vivo translatome profiling in spinal muscular atrophy reveals a role for SMN protein in ribosome biology","volume":"21","author":"Bernab\u00f2","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejcb.2023.151326_bib9","first-page":"10","article-title":"Neuromuscular junctions as key contributors and therapeutic targets in spinal muscular atrophy","author":"Boido","year":"2016","journal-title":"Front Neuroanat."},{"key":"10.1016\/j.ejcb.2023.151326_bib10","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s12031-007-0024-5","article-title":"Smn depletion alters profilin II expression and leads to upregulation of the RhoA\/ROCK pathway and defects in neuronal integrity","volume":"32","author":"Bowerman","year":"2007","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.ejcb.2023.151326_bib11","doi-asserted-by":"crossref","first-page":"26801","DOI":"10.1016\/S0021-9258(18)47090-1","article-title":"Effect of phosphorothioate modification of oligodeoxynucleotides on specific protein binding","volume":"269","author":"Brown","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejcb.2023.151326_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/0165-022X(90)90084-P","article-title":"Oligodeoxynucleoside phosphorothioate stability in subcellular extracts, culture media, sera and cerebrospinal fluid","author":"Campbell","year":"1990","journal-title":"J. Biochem. Biophys. Methods"},{"key":"10.1016\/j.ejcb.2023.151326_bib13","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1038\/emboj.2010.70","article-title":"Specific splicing defects in S. pombe carrying a degron allele of the survival of motor neuron gene","volume":"29","author":"Campion","year":"2010","journal-title":"EMBO J."},{"key":"10.1016\/j.ejcb.2023.151326_bib14","doi-asserted-by":"crossref","first-page":"8126","DOI":"10.1074\/jbc.M512243200","article-title":"Gemin8 is a novel component of the survival motor neuron complex and functions in small nuclear ribonucleoprotein assembly","volume":"281","author":"Carissimi","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejcb.2023.151326_bib15","doi-asserted-by":"crossref","DOI":"10.1111\/j.1440-1681.2006.04403.x","article-title":"Antisense oligonucleotides: from design to therapeutic application","author":"Chan","year":"2006","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.ejcb.2023.151326_bib16","doi-asserted-by":"crossref","DOI":"10.1007\/s00018-018-2849-1","article-title":"The role of survival motor neuron protein (SMN) in protein homeostasis","author":"Chaytow","year":"2018","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ejcb.2023.151326_bib17","article-title":"An antisense oligonucleotide splicing modulator to treat spinal muscular atrophy","author":"Chen","year":"2019","journal-title":"Milestones"},{"key":"10.1016\/j.ejcb.2023.151326_bib18","doi-asserted-by":"crossref","DOI":"10.1007\/BF02088834","article-title":"The application of antisense oligonucleotide technology to the brain: some pitfalls","author":"Chiasson","year":"1994","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.ejcb.2023.151326_bib19","doi-asserted-by":"crossref","unstructured":"Chiriboga, C.A., Swoboda, K.J., Darras, B.T., Iannaccone, S.T., Montes, J., de Vivo, D.C., Norris, D.A., Bennett, C.F., Bishop, K.M., 2016a. Results from a phase 1 study of nusinersen (ISIS-SMN Rx) in children with spinal muscular atrophy.","DOI":"10.1212\/WNL.0000000000002445"},{"key":"10.1016\/j.ejcb.2023.151326_bib20","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1212\/WNL.0000000000002445","article-title":"Results from a phase 1 study of nusinersen (ISIS-SMN Rx) in children with spinal muscular atrophy","volume":"86","author":"Chiriboga","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.ejcb.2023.151326_bib21","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.neurol.2022.12.003","article-title":"Current treatments of spinal muscular atrophy in adults","volume":"179","author":"Cintas","year":"2023","journal-title":"Rev. Neurol."},{"key":"10.1016\/j.ejcb.2023.151326_bib22","article-title":"Interferon Induction Increased through Chemical Modification of a Synthetic Polyribonucleotide","volume":"165","author":"de Clercq","year":"1969","journal-title":"Science (1979)"},{"key":"10.1016\/j.ejcb.2023.151326_bib23","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1093\/hmg\/ddt254","article-title":"Dilysine motifs in exon 2b of SMN protein mediate binding to the COPI vesicle proteina \u03b1-COP and neurite outgrowth in a cell culture model of spinal muscular atrophy","volume":"22","author":"Custer","year":"2013","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.ejcb.2023.151326_bib24","first-page":"6","article-title":"Spinal muscular atrophy","author":"D\u2019Amico","year":"2011","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ejcb.2023.151326_bib25","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.nmd.2021.03.007","article-title":"Newborn screening programs for spinal muscular atrophy worldwide: Where we stand and where to go","volume":"31","author":"Dangouloff","year":"2021","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ejcb.2023.151326_bib26","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.nmd.2019.09.007","article-title":"Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: Interim efficacy and safety results from the Phase 2 NURTURE study","volume":"29","author":"De Vivo","year":"2019","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ejcb.2023.151326_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9062004","article-title":"Antisense oligonucleotides: An emerging area in drug discovery and development","author":"Dhuri","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ejcb.2023.151326_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/nbt.3802","article-title":"Overcoming cellular barriers for RNA therapeutics","author":"Dowdy","year":"2017","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ejcb.2023.151326_bib29","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1093\/brain\/87.4.707","article-title":"Infantile muscular atrophy a prospective study with particular reference to a slowly progressive variety","volume":"87","author":"Dubowitz","year":"1964","journal-title":"Brain"},{"key":"10.1016\/j.ejcb.2023.151326_bib30","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.nmd.2008.10.004","article-title":"Ramblings in the history of spinal muscular atrophy","volume":"19","author":"Dubowitz","year":"2009","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ejcb.2023.151326_bib31","doi-asserted-by":"crossref","DOI":"10.1089\/nat.2014.0506","article-title":"Phosphorothioates, essential components of therapeutic oligonucleotides","author":"Eckstein","year":"2014","journal-title":"Nucleic Acid. Ther."},{"key":"10.1016\/j.ejcb.2023.151326_bib32","first-page":"64","article-title":"Respiratory outcome of spinal muscular atrophy type 1 patients treated with nusinersen","author":"Ergenekon","year":"2022","journal-title":"Pediatr. Int."},{"key":"10.1016\/j.ejcb.2023.151326_bib33","unstructured":"Evrysdi: EPAR - Public assessment report, 2021."},{"key":"10.1016\/j.ejcb.2023.151326_bib34","doi-asserted-by":"crossref","first-page":"3914","DOI":"10.1523\/JNEUROSCI.3631-10.2011","article-title":"The Survival of Motor Neuron (SMN) protein interacts with the mRNA-binding protein HuD and regulates localization of poly(A) mRNA in primary motor neuron axons","volume":"31","author":"Fallini","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejcb.2023.151326_bib35","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/dneu.22111","article-title":"Dynamics of survival of motor neuron (SMN) protein interaction with the mRNA-binding protein IMP1 facilitates its trafficking into motor neuron axons","volume":"74","author":"Fallini","year":"2014","journal-title":"Dev. Neurobiol."},{"key":"10.1016\/j.ejcb.2023.151326_bib36","doi-asserted-by":"crossref","DOI":"10.1086\/338627","article-title":"Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy","author":"Feldk\u00f6tter","year":"2002","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ejcb.2023.151326_bib37","doi-asserted-by":"crossref","DOI":"10.1086\/338627","article-title":"Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy","author":"Feldk\u00f6tter","year":"2002","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ejcb.2023.151326_bib38","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.nmd.2015.04.009","article-title":"209th ENMC international workshop: outcome measures and clinical trial readiness in spinal muscular atrophy 7-9 November 2014, Heemskerk, The Netherlands","volume":"25","author":"Finkel","year":"2015","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ejcb.2023.151326_bib39","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1016\/S0140-6736(16)31408-8","article-title":"Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study","volume":"388","author":"Finkel","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ejcb.2023.151326_bib40","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa1702752","article-title":"Nusinersen versus sham control in infantile-onset spinal muscular atrophy","volume":"377","author":"Finkel","year":"2017","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.ejcb.2023.151326_bib41","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S2352-4642(21)00100-0","article-title":"Treatment of infantile-onset spinal muscular atrophy with nusinersen: final report of a phase 2, open-label, multicentre, dose-escalation study","volume":"5","author":"Finkel","year":"2021","journal-title":"Lancet Child Adolesc. Health"},{"key":"10.1016\/j.ejcb.2023.151326_bib42","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/0092-8674(88)90263-2","article-title":"Cellular Uptake of the Tat Protein from Human lmmunodeficiency Virus","volume":"55","author":"Frankel","year":"1988","journal-title":"Cell"},{"key":"10.1016\/j.ejcb.2023.151326_bib43","first-page":"2","article-title":"Ribonucleoprotein assembly defects correlate with spinal muscular atrophy severity and preferentially affect a subset of spliceosomal snRNPs","author":"Gabanella","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.ejcb.2023.151326_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmed.2012.11.002","article-title":"Spinal muscular atrophy: going beyond the motor neuron","author":"Hamilton","year":"2013","journal-title":"Trends Mol. Med"},{"key":"10.1016\/j.ejcb.2023.151326_bib45","doi-asserted-by":"crossref","first-page":"10962","DOI":"10.1073\/pnas.1605731113","article-title":"Systemic peptide-mediated oligonucleotide therapy improves long-term survival in spinal muscular atrophy","volume":"113","author":"Hammond","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejcb.2023.151326_bib46","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/mus.27034","article-title":"Combination molecular therapies for type 1 spinal muscular atrophy","volume":"62","author":"Harada","year":"2020","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ejcb.2023.151326_bib47","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/NEN.0000000000000144","article-title":"Spectrum of neuropathophysiology in spinal muscular atrophy type i","volume":"74","author":"Harding","year":"2015","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.ejcb.2023.151326_bib48","article-title":"Subcellular mRNA localization in animal cells and why it matters","author":"Holt","year":"2009","journal-title":"Science (1979)"},{"key":"10.1016\/j.ejcb.2023.151326_bib49","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.ajhg.2008.01.014","article-title":"Antisense masking of an hnRNP A1\/A2 intronic splicing silencer corrects SMN2 splicing in transgenic mice","volume":"82","author":"Hua","year":"2008","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ejcb.2023.151326_bib50","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1101\/gad.1941310","article-title":"Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model","volume":"24","author":"Hua","year":"2010","journal-title":"Genes Dev."},{"key":"10.1016\/j.ejcb.2023.151326_bib51","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nature10485","article-title":"Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model","volume":"478","author":"Hua","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ejcb.2023.151326_bib52","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1089\/oli.1.1996.6.267","article-title":"Resistance of morpholino phosphorodiamidate oligomers to enzymatic degradation","volume":"6","author":"Hudziak","year":"1996","journal-title":"Antisense Nucleic Acid. Drug Dev."},{"key":"10.1016\/j.ejcb.2023.151326_bib53","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1093\/hmg\/ddn156","article-title":"Reduced SMN protein impairs maturation of the neuromuscular junctions in mouse models of spinal muscular atrophy","volume":"17","author":"Kariya","year":"2008","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.ejcb.2023.151326_bib54","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1172\/JCI72017","article-title":"Requirement of enhanced Survival Motoneuron protein imposed during neuromuscular junction maturation","volume":"124","author":"Kariya","year":"2014","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejcb.2023.151326_bib55","article-title":"New and developing therapies in spinal muscular atrophy","author":"Kariyawasam","year":"2018","journal-title":"Paediatr. Respir. Rev."},{"key":"10.1016\/j.ejcb.2023.151326_bib56","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1172\/JCI131989","article-title":"Muscle-specific SMN reduction reveals motor neuron\u2013independent disease in spinal muscular atrophy models","volume":"130","author":"Kim","year":"2020","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejcb.2023.151326_bib57","doi-asserted-by":"crossref","DOI":"10.1001\/archneurol.2011.74","article-title":"Spinal muscular atrophy: a timely review","author":"Kolb","year":"2011","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ejcb.2023.151326_bib58","doi-asserted-by":"crossref","first-page":"4795","DOI":"10.1093\/nar\/gkr089","article-title":"Mechanisms of single-stranded phosphorothioate modified antisense oligonucleotide accumulation in hepatocytes","volume":"39","author":"Koller","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.ejcb.2023.151326_bib59","first-page":"75","article-title":"Heredofamilial juvenile muscular atrophy simulating muscular dystrophy","author":"Kugelberg","year":"1956","journal-title":"AMA Arch. Neurol. Psychiatry"},{"key":"10.1016\/j.ejcb.2023.151326_bib60","doi-asserted-by":"crossref","DOI":"10.1046\/j.1432-1033.2003.03555.x","article-title":"Antisense technologies: improvement through novel chemical modifications","author":"Kurreck","year":"2003","journal-title":"Eur. J. Biochem"},{"key":"10.1016\/j.ejcb.2023.151326_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2007.09.002","article-title":"Cell penetrating peptide conjugates of steric block oligonucleotides","author":"Lebleu","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejcb.2023.151326_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/0092-8674(95)90460-3","article-title":"Identification and characterization of a spinal muscular atrophy-determining gene","author":"Lefebvre","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.ejcb.2023.151326_bib63","doi-asserted-by":"crossref","first-page":"7295","DOI":"10.1093\/hmg\/ddv428","article-title":"\u03b1-COP binding to the survival motor neuron protein SMN is required for neuronal process outgrowth","volume":"24","author":"Li","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ejcb.2023.151326_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/S0092-8674(00)80367-0","article-title":"The spinal muscular atrophy disease gene product, SMN, and its associated protein SIP1 are in a complex with spliceosomal snRNP proteins","author":"Liu","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.ejcb.2023.151326_bib65","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/28.2.582","article-title":"Nucleocytoplasmic shuttling: a novel in vivo property of antisense phosphorothioate oligodeoxynucleotides","author":"Lorenz","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejcb.2023.151326_bib66","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.cell.2012.09.012","article-title":"An SMN-dependent U12 splicing event essential for motor circuit function","volume":"151","author":"Lotti","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.ejcb.2023.151326_bib67","article-title":"Spinal muscular atrophy","author":"Lunn","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ejcb.2023.151326_bib68","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1097\/NEN.0b013e3181a10ea1","article-title":"The developmental pattern of myotubes in spinal muscular atrophy indicates prenatal delay of muscle maturation","volume":"68","author":"Mart\u00ednez-Hern\u00e1ndez","year":"2009","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.ejcb.2023.151326_bib69","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines6020051","article-title":"Cell-penetrating peptides to enhance delivery of oligonucleotide-based therapeutics","author":"McClorey","year":"2018","journal-title":"Biomedicines"},{"key":"10.1016\/j.ejcb.2023.151326_bib70","doi-asserted-by":"crossref","DOI":"10.1038\/ncb1101-945","article-title":"A multiprotein complex mediates the ATP-dependent assembly of spliceosomal U snRNPs","author":"Meister","year":"2001","journal-title":"Nat. CELL Biol."},{"key":"10.1016\/j.ejcb.2023.151326_bib71","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1056\/NEJMoa1710504","article-title":"Nusinersen versus sham control in later-onset spinal muscular atrophy","volume":"378","author":"Mercuri","year":"2018","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.ejcb.2023.151326_bib72","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1093\/nar\/gkt066","article-title":"The small molecule Retro-1 enhances the pharmacological actions of antisense and splice switching oligonucleotides","volume":"41","author":"Ming","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejcb.2023.151326_bib73","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1093\/hmg\/ddaa146","article-title":"Pre-natal manifestation of systemic developmental abnormalities in spinal muscular atrophy","volume":"29","author":"Motyl","year":"2020","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.ejcb.2023.151326_bib74","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/sj.embor.embor863","article-title":"Interaction between the small-nuclear-RNA cap hypermethylase and the spinal muscular atrophy protein, survival of motor neuron","volume":"4","author":"Mouaikel","year":"2003","journal-title":"EMBO Rep."},{"key":"10.1016\/j.ejcb.2023.151326_bib75","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0960-8966(06)80015-5","article-title":"International SMA consortium meeting (26\u201328 June 1992, Bonn, Germany","volume":"2","author":"Munsat","year":"1992","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ejcb.2023.151326_bib76","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/9.1.47","article-title":"Subcellular localization and axonal transport of the survival motor neuron (SMN) protein in the developing rat spinal cord","author":"Pagliardini","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ejcb.2023.151326_bib77","first-page":"3","article-title":"Antisense oligonucleotides delivered to the mouse CNS ameliorate symptoms of severe spinal muscular atrophy","author":"Passini","year":"2011","journal-title":"Sci. Transl. Med"},{"key":"10.1016\/j.ejcb.2023.151326_bib78","article-title":"Essential role for the SMN complex in the specificity of snRNP assembly","author":"Pellizzoni","year":"2002","journal-title":"Sci. (1979) 298, 1775\u20131779"},{"key":"10.1016\/j.ejcb.2023.151326_bib79","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1093\/hmg\/ddr046","article-title":"The COPI vesicle complex binds and moves with survival motor neuron within axons","volume":"20","author":"Peter","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ejcb.2023.151326_bib80","doi-asserted-by":"crossref","DOI":"10.1053\/j.semperi.2015.03.006","article-title":"Newborn screening for spinal muscular atrophy: anticipating an imminent need","author":"Phan","year":"2015","journal-title":"Semin Perinatol."},{"key":"10.1016\/j.ejcb.2023.151326_bib81","first-page":"313","article-title":"Basic principles of using antisense oligonucleotides in vivo","author":"Phillips","year":"1999","journal-title":"Methods Enzym."},{"key":"10.1016\/j.ejcb.2023.151326_bib82","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1093\/hmg\/ddr600","article-title":"A single administration of morpholino antisense oligomer rescues spinal muscular atrophy in mouse","volume":"21","author":"Porensky","year":"2012","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.ejcb.2023.151326_bib83","doi-asserted-by":"crossref","DOI":"10.1128\/MCB.19.10.6554","article-title":"Spliceosomal U snRNP core assembly: sm proteins assemble onto an Sm site RNA nonanucleotide in a specific and thermodynamically stable manner","author":"Raker","year":"1999","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ejcb.2023.151326_bib84","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ajhg.2017.01.005","article-title":"Neurocalcin delta suppression protects against spinal muscular atrophy in humans and across species by restoring impaired endocytosis","volume":"100","author":"Riessland","year":"2017","journal-title":"Am. J. Hum. Genet"},{"key":"10.1016\/j.ejcb.2023.151326_bib85","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1124\/jpet.113.212407","article-title":"Pharmacology of a central nervous system delivered 2\u2032-O-methoxyethyl- modified survival of motor neuron splicing oligonucleotide in mice and nonhuman primates","volume":"350","author":"Rigo","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejcb.2023.151326_bib86","doi-asserted-by":"crossref","DOI":"10.1038\/nrneurol.2017.148","article-title":"Antisense oligonucleotides: the next frontier for treatment of neurological disorders","author":"Rinaldi","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.ejcb.2023.151326_bib87","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1083\/jcb.200304128","article-title":"Smn, the spinal muscular atrophy-determining gene product, modulates axon growth and localization of \u03b2-actin mRNA in growth cones of motoneurons","volume":"163","author":"Rossoll","year":"2003","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ejcb.2023.151326_bib88","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/mus.21654","article-title":"Digital necroses and vascular thrombosis in severe spinal muscular atrophy","volume":"42","author":"Rudnik-Sch\u00f6neborn","year":"2010","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ejcb.2023.151326_bib89","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/hmg\/ddt567","article-title":"SMN deficiency alters Nrxn2 expression and splicing in zebrafish and mouse models of spinal muscular atrophy","volume":"23","author":"See","year":"2014","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.ejcb.2023.151326_bib90","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1093\/nar\/gkaa126","article-title":"Comparison of the efficacy of MOE and PMO modifications of systemic antisense oligonucleotides in a severe SMA mouse model","volume":"48","author":"Sheng","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.ejcb.2023.151326_bib91","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1128\/MCB.26.4.1333-1346.2006","article-title":"Splicing of a critical exon of human survival motor neuron is regulated by a unique silencer element located in the last intron","volume":"26","author":"Singh","year":"2006","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.ejcb.2023.151326_bib92","doi-asserted-by":"crossref","DOI":"10.1038\/gt.2017.34","article-title":"How the discovery of ISS-N1 led to the first medical therapy for spinal muscular atrophy","author":"Singh","year":"2017","journal-title":"Gene Ther."},{"key":"10.1016\/j.ejcb.2023.151326_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbagrm.2016.12.008","article-title":"Diverse role of survival motor neuron protein","author":"Singh","year":"2017","journal-title":"Biochim Biophys. Acta Gene Regul. Mech."},{"key":"10.1016\/j.ejcb.2023.151326_bib94","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/16.8.3209","article-title":"Physicochemical properties of phosphorothioate oligodeoxynucleotides","author":"Stein","year":"1988","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejcb.2023.151326_bib95","article-title":"Inhibition of Rous sarcoma viral RNA translation by a specific oligodeoxyribonucleotide (in vitro protein synthesis\/nucleic acid hybridization\/DNA nucleotidyltransferase)","author":"Stephenson","year":"1978","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejcb.2023.151326_bib96","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1089\/oli.1.1997.7.187","article-title":"Morpholino antisense oligomers design, preparation, and properties","volume":"7","author":"Summerton","year":"1997","journal-title":"Antisense Nucleic Acid. Drug Dev."},{"key":"10.1016\/j.ejcb.2023.151326_bib97","series-title":"Morpholino Oligomers: Methods and Protocols","first-page":"1","article-title":"Invention and early history of morpholinos: from pipe dream to practical products","author":"Summerton","year":"2017"},{"key":"10.1016\/j.ejcb.2023.151326_bib98","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1021\/acs.biomac.5b01334","article-title":"SiRNA-loaded polyion complex micelle decorated with charge-conversional polymer tuned to undergo stepwise response to intra-tumoral and intra-endosomal phs for exerting enhanced RNAi efficacy","volume":"17","author":"Tangsangasaksri","year":"2016","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ejcb.2023.151326_bib99","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1093\/hmg\/dds480","article-title":"COPI transport complexes bind to specific RNAs in neuronal cells","volume":"22","author":"Todd","year":"2013","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.ejcb.2023.151326_bib100","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp-2016-314292","article-title":"Association of motor milestones, SMN2 copy and outcome in spinal muscular atrophy types 0-4","author":"Wadman","year":"2017","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.ejcb.2023.151326_bib101","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/BF01776636","article-title":"Zwei fr\u00fchinfantile heredit\u00e4re F\u00e4lle von progressiver Muskelatrophie unter dem Bilde der Dystrophie, aber anf neurotischer Grundlage","volume":"22","author":"Werdnig","year":"1891","journal-title":"Arch. Psychiatr. Nervenkr"},{"key":"10.1016\/j.ejcb.2023.151326_bib102","doi-asserted-by":"crossref","first-page":"7633","DOI":"10.1523\/JNEUROSCI.0950-09.2009","article-title":"Oligonucleotide-mediated survival of motor neuron protein expression in CNS improves phenotype in a mouse model of spinal muscular atrophy","volume":"29","author":"Williams","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejcb.2023.151326_bib103","first-page":"395","article-title":"Hereditary proximal spinal muscular atrophy, a clinical entity simulating progressive muscular dystrophy","volume":"30","author":"Wohlfart","year":"1955","journal-title":"Acta Psychiatr. Neurol. Scand."},{"key":"10.1016\/j.ejcb.2023.151326_bib104","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1093\/nar\/gkv060","article-title":"High-throughput screening identifies small molecules that enhance the pharmacological effects of oligonucleotides","volume":"43","author":"Yang","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.ejcb.2023.151326_bib105","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1073\/pnas.75.1.280","article-title":"Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide","volume":"75","author":"Zamecnik","year":"1978","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejcb.2023.151326_bib106","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.cell.2008.03.031","article-title":"SMN deficiency causes tissue-specific perturbations in the repertoire of snRNAs and widespread defects in splicing","volume":"133","author":"Zhang","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.ejcb.2023.151326_bib107","unstructured":"Zolgensma: EPAR - Public assessment report, 2020."}],"container-title":["European Journal of Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171933523000419?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171933523000419?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T17:28:15Z","timestamp":1759253295000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0171933523000419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":107,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S0171933523000419"],"URL":"https:\/\/doi.org\/10.1016\/j.ejcb.2023.151326","relation":{},"ISSN":["0171-9335"],"issn-type":[{"value":"0171-9335","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Challenges and future perspective of antisense therapy for spinal muscular atrophy: A review","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cell Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejcb.2023.151326","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"151326"}}